107 results
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
in unexpected costs, organizational disruption, adverse effects on employee morale, retention issues or other unintended consequences;
the ability
8-K
EX-99
PFE
Pfizer Inc.
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
effects on employee morale, retention issues or other unintended consequences;
the ability to successfully achieve our climate goals and progress our
8-K
EX-1.1
1dhazpjn
19 May 23
Other Events
4:26pm
8-K
EX-1.1
ooeswymdb6 usz8ifp5r
18 Aug 21
Other Events
4:06pm
8-K
na9djhy7
13 Nov 20
Unregistered Sales of Equity Securities
5:05pm
8-K
EX-99.1
oa7l03
5 Nov 20
Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock
4:42pm
8-K
EX-99.1
niphf
30 Oct 20
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
5:10pm
8-K
883admwgs 5z5iy
6 Aug 20
Regulation FD Disclosure
5:23pm
8-K
EX-99.1
gmkqetgobehx
6 Aug 20
Regulation FD Disclosure
5:23pm
425
t9rlk 11z0s
26 Jun 20
Business combination disclosure
5:05pm
8-K
6qpt83v2
26 Jun 20
Other Events
5:03pm
425
ydzek ync
18 Jun 20
Business combination disclosure
5:01pm
425
juaga7rrj0i
1 Jun 20
Business combination disclosure
5:27pm
8-K
EX-2.2
05kzb 0m8pv9
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm
8-K
6wwtudgo4eg66oo9fk
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm